Journal of Clinical Endocrinology & Metabolism, Vol 80, 591-594, Copyright © 1995 by Endocrine Society

ARTICLES

Gonadotroph adenoma in a premenopausal woman secreting follicle- stimulating hormone and causing ovarian hyperstimulation

A Djerassi, C Coutifaris, VA West, SL Asa, SC Kapoor, SN Pavlou and PJ Snyder
Division of Endocrinology, University of Pennsylvania School of Medicine, Philadelphia 19104.

The clinical manifestations of gonadotroph adenomas are almost always neurological, consequences of their large size, and are rarely endocrinological. We report an exception, a 39-yr-old woman whose gonadotroph adenoma caused supranormal serum concentrations of FSH, which resulted in the development of multiple ovarian cysts, persistent elevation of her serum estradiol concentration, and endometrial hyperplasia. She initially presented because of amenorrhea at age 30 yr and was treated for an intrasellar mass by transsphenoidal surgery at age 31 yr and again at age 36 yr. Before and after the second operation she had persistently supranormal plasma estradiol concentrations (> 1840 pmol/L) and endometrial hyperplasia. When she was evaluated at age 39 yr, transvaginal ultrasound showed multiple ovarian cysts and endometrial thickening. Her plasma estradiol level was markedly supranormal (2160 pmol/L), FSH was mildly supranormal (17.8 IU/L), and alpha-subunit was markedly supranormal (23.3 micrograms/L). Characteristic of gonadotroph adenomas, her LH beta level increased by 69% in response to TRH. Neither FSH nor alpha-subunit decreased in response to administration of the GnRH antagonist, Nal-Glu-GnRH (5 mg/12 h for 4 weeks). Excised adenoma tissue exhibited morphological features of a gonadotroph adenoma. This patient appears to be unique, in that her gonadotroph adenoma caused slightly, but persistently, supranormal concentrations of FSH, which caused ovarian stimulation, including supranormal plasma estradiol concentrations, multiple ovarian cysts, and endometrial hyperplasia. We propose that gonadotroph adenomas be considered in the differential diagnosis of patients who have this constellation of abnormalities.

This article has been cited by other articles:

				T. Kajitani, S. Liu, T. Maruyama, H. Uchida, R. Sakurai, H. Masuda, T. Nagashima, M. Ono, T. Arase, and Y. Yoshimura Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report Hum. Reprod., February 1, 2008; 23(2): 435 - 439. [Abstract] [Full Text] [PDF]

				M. Ghayuri and J. H. Liu Ovarian Hyperstimulation Syndrome Caused by Pituitary Gonadotroph Adenoma Secreting Follicle-Stimulating Hormone Obstet. Gynecol., February 1, 2007; 109(2): 547 - 549. [Abstract] [Full Text] [PDF]

				T. Maruyama, H. Masuda, H. Uchida, T. Nagashima, and Y. Yoshimura Follicle Stimulating Hormone-Secreting Pituitary Microadenoma With Fluctuating Levels of Ovarian Hyperstimulation Obstet. Gynecol., May 1, 2005; 105(5): 1215 - 1218. [Abstract] [Full Text] [PDF]

				M. Benito, S. L. Asa, V. A. LiVolsi, V. A. West, and P. J. Snyder Gonadotroph Tumor Associated with Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 570 - 574. [Abstract] [Full Text] [PDF]

				Y. Murata, H. Ando, T. Nagasaka, I. Takahashi, K. Saito, H. Fukugaki, K. Matsuzawa, and S. Mizutani Successful Pregnancy after Bromocriptine Therapy in an Anovulatory Woman Complicated with Ovarian Hyperstimulation Caused by Follicle-Stimulating Hormone-Producing Plurihormonal Pituitary Microadenoma J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1988 - 1993. [Abstract] [Full Text] [PDF]

				I. Shimon, T. Rubinek, I. Bar-Hava, D. Nass, M. Hadani, A. Amsterdam, and G. Harel Ovarian Hyperstimulation without Elevated Serum Estradiol Associated with Pure Follicle-Stimulating Hormone-Secreting Pituitary Adenoma J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3635 - 3640. [Abstract] [Full Text] [PDF]

				A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]

				M. J. Välimäki, A. Tiitinen, H. Alfthan, A. Paetau, A. Poranen, T. Sane, and U.-H. Stenman Ovarian Hyperstimulation Caused by Gonadotroph Adenoma Secreting Follicle-Stimulating Hormone in 28-Year-Old Woman J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4204 - 4208. [Abstract] [Full Text]

				B. Catargi, E. Felicie-Dellan, and A. Tabarin Comment on Gonadotroph Adenoma Causing Ovarian Hyperstimulation J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3404 - 3404. [Full Text]

				T. R. Kumar, G. Palapattu, P. Wang, T. K. Woodruff, I. Boime, M. C. Byrne, and M. M. Matzuk Transgenic Models to Study Gonadotropin Function: The Role of Follicle-Stimulating Hormone in Gonadal Growth and Tumorigenesis Mol. Endocrinol., June 1, 1999; 13(6): 851 - 865. [Abstract] [Full Text]

				S. Christin-Maitre, C. Rongières-Bertrand, M.-L. Kottler, N. Lahlou, R. Frydman, P. Touraine, and P. Bouchard A Spontaneous and Severe Hyperstimulation of the Ovaries Revealing a Gonadotroph Adenoma J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3450 - 3453. [Abstract] [Full Text]

				J. C. Prior Perimenopause: The Complex Endocrinology of the Menopausal Transition Endocr. Rev., August 1, 1998; 19(4): 397 - 428. [Abstract] [Full Text] [PDF]